# Osteocel® Plus in eXtreme Lateral Interbody Fusion (XLIF®)

> **NCT00948532** · — · COMPLETED · sponsor: **NuVasive** · enrollment: 104 (actual)

## Conditions studied

- Degenerative Disc Disease
- Back Pain

## Interventions

- **BIOLOGICAL:** biologic, Osteocel Plus

## Key facts

- **NCT ID:** NCT00948532
- **Lead sponsor:** NuVasive
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00948532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00948532, "Osteocel® Plus in eXtreme Lateral Interbody Fusion (XLIF®)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00948532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*